Press "Enter" to skip to content

Posts published in “Investment”

The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine

Here’s a roundup of top developments in the biotech space over the last 24 hours. The FDA has issued a Complete Response Letter (CRL) regarding Verrica Pharmaceuticals Inc’s VRCA…

ENSERVCO CORPORATION CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Colorado against Enservco Corporation

LEAD PLAINTIFF DEADLINE IS JULY 19, 2022 NEW YORK, May 25, 2022 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces that a…